Publications

• Liana B. Guedes, Fawaz Almutairi, Michael Haffner, Gaurav Rajoria, Zach Liu, Szczepan Klimek, Roberto Zoino, Kasra Yousefi, Rajni Sharma, Angelo M. De Marzo, George J. Netto, William B. Isaacs, Ashley E. Ross, Edward M. Schaeffer and Tamara L. Lotan Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer Clinical Cancer Res. 2017; 15; 23(16): 4693-4703.
• Henry Y. Dong, James Weisberger, Zach Liu, and Sorina Tugulea. Immunophenotypic Analysis of CD103+ B-Lymphoproliferative Disorders Hairy Cell Leukemia and It’s Mimics. American Journal of Clinical Pathology 2009; 131:58 -595.
• Dong HY, P Brown, Zach Liu and M Gangi. PAX-5 is invariably expressed in B-cell lymphomas without plasma cell differentiation. Histopathology 2008; 53: 278-287.
• Gorczyca G, Tugulea S, Zach Liu, et al. Flow Cytometry in the Diagnosis of Mediastinal Tumors with Emphasis on Differentiating Thymocytes from Precursor T-Lymphoblastic Lymphoma/Leukemia. Leukemia/Lymphoma. 2004; 45:529-538.

Publications

• Mouritsen CL, Litwin CM, Maiese RL, Segal SM, Segal GH. Rapid PCR-based detection of the causative agent of cat scratch disease (Bartonella henselae) in formalin-fixed, paraffin-embedded samples.  HUM PATHOL 1997; 28:820-826.
• Lombardo JF, Hwang, TS, Maiese RL, Millson A, Segal GH. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: III.  Intermediate and high grade B-cell neoplasms.  HUM PATHOL 1996; 27:373-380.
• Segal GH, Jorgensen T, Masih AS, Braylan RC. Optimal primer selection for clonality assessment by polymerase chain reaction analysis:  Low grade B-cell lymphoproliferative disorders of non-follicular center cell type.  HUM PATHOL 1994; 24:1269-1275.
• Segal GH, Jorgensen T, Scott M, Braylan RC. Optimal primer selection for clonality assessment by polymerase chain reaction analysis:  Follicular lymphomas.  HUM PATHOL 1994; 24:1276-1282.

Publications

• Soma L, Oehler VG, Ding C, Cherian S. Small, abnormal B lymphoid blast populations in chronic myelogenous leukemia at diagnosis: Does this finding indicate an accelerated course? Cytometry B Clin Cytom. 2016 Sep;90(5):440-8
• Cohen J, Dorai T, Ding C, Batinic-Haberle I, Grasso M. The administration of renoprotective agents extends warm ischemia in a rat model. Journal of Endourolology. 2013 Mar;27(3):343-8
• Dorai T, Fishman A, Ding C, Batinic-Haberle I, Goldfarb D, and Grasso M. Amelioration of Renal Ischemia-Reperfusion Injury with a Novel Protective Cocktail. Journal of Urology. 2011 Dec;186(6):2448-54.
• Ding C, Liu Y, Wang Y, Park BK, Wang CY, Zheng P and LiuY. Siglec-G limits the size of B-1a B cell lineage by repressing NF-kB activation. Plos One. 2007 Oct 3; 2(10).

Publications

• Boggan JC, Walmer DK, Henderson GS, Chakhtoura N, McCarthy SH, Beauvais HJ, Smith JS. “Vaginal self-sampling for human papillomavirus infection as a primary cervical cancer screening tool in a Haitian population”. Sexually Transmitted Diseases. 2015 Nov;42(11):655-59.
• Mignano JD, Gage I, Piantadosi S, Ye X, Henderson G, Dooley WC. “Local recurrence after mastectomy in patients with T3pN0 breast carcinoma treated without postoperative radiation therapy”. Am J Clin Oncol. 2007 Oct 30(5):466-72.
• Powell JL, Connor GP, Henderson GS. “Management of recurrent juvenile granulosa cell tumor of the ovary”. Gynecol Oncol. 2001 Apr;81(1):113-6.

Publications

• Douglas Charney, Kim Solez and Lorraine C. Racusen.  “Nephrotoxicity of Cyclosporine and Other Immunosuppressive and Immunotherapeutic Agents, in Toxicology of the Kidney”, 3^rd Edition, December 2004.  Taylor and Francis Books, Inc.
• Charney DA, Nassar G, Truong L, Nadasdy T.  “Pauci-Immune Proliferative and Necrotizing Glomerulonephritis with Thrombotic Microangiopathy in Patients with Systemic Lupus Erythematosus and Lupus-like Syndrome”.  American Journal of Kidney Disease 2000; 35:1193-206.
• Douglas A. Charney, Ashutosh Singh and Narcis Aron. “A male  nephrotic patient with rapid decline of renal function”. Nephrology Dialysis Transplantation. 2005;20 (6): 1263

Publications

• Taouli B, Losada M, Holland A, Krinsky G. “MR Imaging of Hepatocellular Carcinoma”. Gastroenterology 2004; 127: S144-152.
• West AB, Losada M. “The Pathology of Diverticulosis Coli”. J Clin Gastroenterol, 2004 May-Jun; 38(5 Suppl):S11-6
• Ye H, Losada M, West AB. “Diverticulosis Coli: Update on a ‘Western’ Disease”. Advances in Anatomic Pathology 2005 Mar;12(2):74-80.
• Saindane AM, Losada M, Macari M. “Focal Amyloidoma of the Small Bowel Mimicking Adenocarcinoma on CT”. AJR Am J Roentgenol 2005;185:1187-9.

Publications

• Yijun Guo, MD, PhD, FCAP, USCAP. Guo YJ (co-first author), Zhao Y (co-first author), Tomac AC, Taylor NR, Grinberg A, Lee EJ, Huang S, Westphal H. “Isolated Cleft Palate in Mice with a Targeted Mutation of the LIM Homeobox Gene lhx8”. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15002-6. 

Publications

• Nagi CS, O’Donnell JE, Tismenetsky M, Bleiweiss IJ, Shabnam Jaffer. “Lobular Neoplasia on  Core Needle Biopsy Does Not Require Excision”.  Cancer 2008; 112:10:2152-2158.

Publications

• Mascarello, JT, Cooley, LD, Dowling, PK, et al., CLSI. “Fluorescence in situ Hybridization Methods for Clinical Laboratories; Approved Guideline – Second Edition”. CLSI document MMO7-A2. Wayne, Pa: Clinical and Laboratory Standards Institute, 2013
• Gu J., Smith J.L., Dowling P.K. (2017) “Fluorescence In Situ Hybridization Probe Validation for Clinical Use. In: Wan T. (eds) Cancer Cytogenetics”. Methods in Molecular Biology, vol 1541. Humana Press, New York, NY
• Dowling, P, chapter author, “Mathematics for the cytogenetic technologist”; chapter 19, in The AGT Cytogenetics Laboratory Manual, Fourth Edition; Editor(s): Marilyn S. Arsham, Margaret J. Barch M.S., CG(ASCP)CM, Helen J. Lawce B.S., CG(ASCP)CM, Wiley, 2017.